IRIS
MERLOTTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.898
EU - Europa 5.094
AS - Asia 3.374
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 128
OC - Oceania 8
Totale 16.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.776
CN - Cina 1.129
SG - Singapore 1.103
RU - Federazione Russa 1.082
IT - Italia 823
GB - Regno Unito 796
IE - Irlanda 736
BR - Brasile 513
UA - Ucraina 389
SE - Svezia 337
VN - Vietnam 332
FR - Francia 310
HK - Hong Kong 264
DE - Germania 262
KR - Corea 172
FI - Finlandia 160
IN - India 91
ZA - Sudafrica 66
CA - Canada 62
BD - Bangladesh 48
AR - Argentina 47
ES - Italia 37
NL - Olanda 36
TR - Turchia 36
IQ - Iraq 28
MX - Messico 27
PL - Polonia 24
JP - Giappone 23
BE - Belgio 20
PK - Pakistan 19
SA - Arabia Saudita 17
ID - Indonesia 15
LT - Lituania 15
CI - Costa d'Avorio 14
CL - Cile 14
AT - Austria 12
EC - Ecuador 11
NP - Nepal 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
KE - Kenya 10
VE - Venezuela 10
MY - Malesia 9
CO - Colombia 8
IR - Iran 8
NG - Nigeria 8
HU - Ungheria 7
JO - Giordania 7
DO - Repubblica Dominicana 6
EU - Europa 6
PE - Perù 6
TH - Thailandia 6
AZ - Azerbaigian 5
CH - Svizzera 5
CR - Costa Rica 5
DK - Danimarca 5
GR - Grecia 5
IL - Israele 5
MA - Marocco 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ET - Etiopia 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
BB - Barbados 3
BO - Bolivia 3
DZ - Algeria 3
GE - Georgia 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SC - Seychelles 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
Totale 16.114
Salva come PNG Salva come JPEG
Città #
Dallas 791
Dublin 726
Fairfield 692
Southend 639
Singapore 565
Ashburn 512
Santa Clara 404
Chandler 319
Jacksonville 310
Woodbridge 304
Moscow 283
Houston 268
Beijing 256
Hong Kong 251
Milan 249
Wilmington 248
Seattle 242
Cambridge 241
San Jose 222
Council Bluffs 218
Hefei 214
Ann Arbor 179
Seoul 170
Princeton 138
The Dalles 117
Los Angeles 102
Ho Chi Minh City 101
Nanjing 92
Rome 87
Siena 87
Lauterbourg 86
Helsinki 80
Hanoi 75
Johannesburg 56
New York 53
Boardman 48
Buffalo 46
Shanghai 46
London 44
San Diego 44
Munich 43
Nanchang 43
Columbus 42
São Paulo 39
Dong Ket 36
San Mateo 30
Dearborn 27
Tianjin 27
Shenyang 26
Orem 25
Redondo Beach 25
Da Nang 24
Izmir 24
San Francisco 23
Bengaluru 22
Figino 21
Montreal 21
Brussels 20
Tokyo 20
Boston 19
Brooklyn 19
Denver 19
Málaga 19
Redwood City 19
Warsaw 19
Florence 18
Düsseldorf 17
Hebei 17
Kunming 17
Naples 17
Turin 17
Chicago 16
Jiaxing 16
Toronto 16
Changsha 15
Rio de Janeiro 15
Abidjan 14
Atlanta 14
Bologna 14
Turku 14
Venezia 14
Belo Horizonte 13
Chennai 13
Frankfurt am Main 13
Poplar 13
Haiphong 12
Manchester 12
Nuremberg 12
Riyadh 12
Amsterdam 11
Mumbai 11
Norwalk 11
Porto Alegre 11
Portsmouth 11
Stockholm 11
Brasília 10
Fremont 10
Guangzhou 10
Hangzhou 10
Phoenix 10
Totale 10.724
Salva come PNG Salva come JPEG
Nome #
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 309
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 276
Aromatase activity and bone loss in men 259
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 259
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 249
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 248
Bazedoxifene for the prevention of postmenopausal osteoporosis 247
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 239
Endocrine actions of osteocalcin 230
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 229
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 228
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 228
Aromatase activity and bone loss 221
Bone metabolism in men: role of aromatase activity 219
Corretto uso dei marcatori del rimodellamento osseo 219
Update on the pathogenesis and genetics of Paget's disease of bone 216
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 209
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 209
Appropriate models for novel osteoporosis drug discovery and future perspectives 207
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 204
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 202
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 201
The influence of weight and length at birth on bone status during childhood as evaluated by QUS 199
CALCITRIOLO E OSTEOPOROSI 199
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 197
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 197
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 195
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 195
The effects of zoledronic acid on serum lipids in multiple myeloma patients 194
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 194
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 187
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 187
Vescicole extracellulari e metabolismo osseo: ruolo e possibili implicazioni cliniche 186
Aromatase deficiency and male osteoporosis 185
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 184
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 183
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 182
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 180
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 178
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 176
Mechanisms of impaired bone strength in type 1 and 2 diabetes 176
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 175
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 174
Prevalence of Paget’s disease of bone in Italy 174
MicroRNAs in bone diseases 173
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 171
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 170
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 169
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 168
Bone fragility in men: where are we? 168
Perspectives in the treatment and prevention of osteoporosis 168
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 166
Ospemifene use in postmenopausal women 162
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 161
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification 157
Recent advances in models for screening potential osteoporosis drugs 156
Lasofoxifene: Evidence of its therapeutic value in osteoporosis 155
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 155
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 153
Interleukin-6 trans-signaling and pathological low back pain in patients with Paget disease of bone 152
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 149
Relationship of sex hormones with bone turnover markers, bone ultrasounds and BMD at multiple sites in men and women 149
Raloxifene in breast cancer prevention 148
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 147
Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation 146
Vitamin D deficiency and primary hyperparathyroidism 144
Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women 144
The Potential Role of miRNAs as New Biomarkers for Osteoporosis 142
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy 139
Current options for the treatment of Paget's disease of the bone 138
Treatment options for glucocorticoid-induced osteoporosis 135
Drug treatment strategies for paget’s disease: relieving pain and preventing progression 134
Micro-RNA expression profiling in Paget's disease of bone 133
Emerging therapeutic targets for osteoporosis 133
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 130
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development 128
Professional sport activity and micronutrients: effects on bone mass 128
null 128
Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis 126
Clinical Characteristics and Evolution of Giant Cell Tumor Occurring in Paget's Disease of Bone 125
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy 124
MANAGEMENT STRATEGIES FOR OSTEOPOROSIS IN THE AGING MALE: FOCUS ON ZOLEDRONIC ACID 124
null 122
Paget's disease of bone 120
Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol 119
Oncogenic osteomalacia 118
Treatment needs and current options for postmenopausal osteoporosis 117
la genetica dell'osteoporosi 116
Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility 107
null 105
Energy metabolism and ketogenic diets: What about the skeletal health? a narrative review and a prospective vision for planning clinical trials on this issue 103
null 103
Management of bone fragility in type 2 diabetes:Perspective from an interdisciplinary expert panel 103
Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu 97
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 95
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis 80
Totale 16.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022803 0 107 41 109 24 25 36 23 44 105 88 201
2022/20231.233 81 90 184 164 120 262 26 95 117 33 40 21
2023/20241.157 123 48 112 45 19 245 389 17 7 28 33 91
2024/20252.610 47 128 188 128 382 189 96 149 234 121 243 705
2025/20265.660 503 863 566 643 978 252 555 151 185 321 160 483
2026/2027377 212 165 0 0 0 0 0 0 0 0 0 0
Totale 16.308